Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
36
SMGRF Quote, Financials, Valuation and Earnings
Last price:
$6.97
Seasonality move
:
-2.08%
Day range:
$6.97 - $6.97
52-week range:
$6.97 - $7.33
Dividend yield:
2.02%
P/E ratio:
7.89x
P/S ratio:
8.25x
P/B ratio:
1.06x
Volume:
--
Avg. volume:
17
1-year change:
-4.91%
Market cap:
$1.7B
Revenue:
$192.7M
EPS (TTM):
$0.61
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SMGRF
Summerset Group Holdings Ltd.
|
-- | -- | -- | -- | -- |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$292.5M | $0.14 | 13.44% | 28.72% | $31.21 |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
-- | -- | -- | -- | -- |
|
PFGTF
Pacific Edge Ltd.
|
-- | -- | -- | -- | -- |
|
RHCGF
Ryman Healthcare Ltd.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SMGRF
Summerset Group Holdings Ltd.
|
$6.97 | -- | $1.7B | 7.89x | $0.07 | 2.02% | 8.25x |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$23.99 | $31.21 | $4.1B | 15.44x | $0.00 | 0% | 3.86x |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
$22.10 | -- | $13B | 51.00x | $0.17 | 1.59% | 10.22x |
|
PFGTF
Pacific Edge Ltd.
|
$0.23 | -- | $237.9M | -- | $0.00 | 0% | 19.89x |
|
RHCGF
Ryman Healthcare Ltd.
|
$1.41 | -- | $705M | -- | $0.00 | 0% | 2.72x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SMGRF
Summerset Group Holdings Ltd.
|
36.6% | -0.062 | -- | 0.11x |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
5.64% | 2.900 | 1.52% | 2.70x |
|
AROAF
Aroa Biosurgery
|
-- | 0.000 | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
3.28% | 1.642 | -- | 1.14x |
|
PFGTF
Pacific Edge Ltd.
|
1.14% | -4.632 | -- | 2.82x |
|
RHCGF
Ryman Healthcare Ltd.
|
-- | 2.214 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SMGRF
Summerset Group Holdings Ltd.
|
-- | -- | 5.8% | 12.83% | -- | -- |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$257M | $35.8M | 31.98% | 34.23% | 12.83% | $73.9M |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
$299.7M | -$209.7M | 18.6% | 19.71% | 40.18% | -- |
|
PFGTF
Pacific Edge Ltd.
|
-- | -- | -69.68% | -72.02% | -- | -- |
|
RHCGF
Ryman Healthcare Ltd.
|
-- | -- | -- | -- | -- | -- |
Summerset Group Holdings Ltd. vs. Competitors
-
Which has Higher Returns SMGRF or ACAD?
ACADIA Pharmaceuticals, Inc. has a net margin of -- compared to Summerset Group Holdings Ltd.'s net margin of 25.76%. Summerset Group Holdings Ltd.'s return on equity of 12.83% beat ACADIA Pharmaceuticals, Inc.'s return on equity of 34.23%.
Company Gross Margin Earnings Per Share Invested Capital SMGRFSummerset Group Holdings Ltd.-- -- $2.6B ACADACADIA Pharmaceuticals, Inc.92.23% $0.42 $972.1M -
What do Analysts Say About SMGRF or ACAD?
Summerset Group Holdings Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand ACADIA Pharmaceuticals, Inc. has an analysts' consensus of $31.21 which suggests that it could grow by 30.1%. Given that ACADIA Pharmaceuticals, Inc. has higher upside potential than Summerset Group Holdings Ltd., analysts believe ACADIA Pharmaceuticals, Inc. is more attractive than Summerset Group Holdings Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SMGRFSummerset Group Holdings Ltd.0 0 0 ACADACADIA Pharmaceuticals, Inc.9 6 1 -
Is SMGRF or ACAD More Risky?
Summerset Group Holdings Ltd. has a beta of -0.179, which suggesting that the stock is 117.891% less volatile than S&P 500. In comparison ACADIA Pharmaceuticals, Inc. has a beta of 0.660, suggesting its less volatile than the S&P 500 by 33.951%.
-
Which is a Better Dividend Stock SMGRF or ACAD?
Summerset Group Holdings Ltd. has a quarterly dividend of $0.07 per share corresponding to a yield of 2.02%. ACADIA Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Summerset Group Holdings Ltd. pays 16.94% of its earnings as a dividend. ACADIA Pharmaceuticals, Inc. pays out -- of its earnings as a dividend. Summerset Group Holdings Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMGRF or ACAD?
Summerset Group Holdings Ltd. quarterly revenues are --, which are smaller than ACADIA Pharmaceuticals, Inc. quarterly revenues of $278.6M. Summerset Group Holdings Ltd.'s net income of -- is lower than ACADIA Pharmaceuticals, Inc.'s net income of $71.8M. Notably, Summerset Group Holdings Ltd.'s price-to-earnings ratio is 7.89x while ACADIA Pharmaceuticals, Inc.'s PE ratio is 15.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Summerset Group Holdings Ltd. is 8.25x versus 3.86x for ACADIA Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMGRFSummerset Group Holdings Ltd.8.25x 7.89x -- -- ACADACADIA Pharmaceuticals, Inc.3.86x 15.44x $278.6M $71.8M
-
Which has Higher Returns SMGRF or AROAF?
Aroa Biosurgery has a net margin of -- compared to Summerset Group Holdings Ltd.'s net margin of --. Summerset Group Holdings Ltd.'s return on equity of 12.83% beat Aroa Biosurgery's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SMGRFSummerset Group Holdings Ltd.-- -- $2.6B AROAFAroa Biosurgery-- -- -- -
What do Analysts Say About SMGRF or AROAF?
Summerset Group Holdings Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Aroa Biosurgery has an analysts' consensus of -- which suggests that it could fall by --. Given that Summerset Group Holdings Ltd. has higher upside potential than Aroa Biosurgery, analysts believe Summerset Group Holdings Ltd. is more attractive than Aroa Biosurgery.
Company Buy Ratings Hold Ratings Sell Ratings SMGRFSummerset Group Holdings Ltd.0 0 0 AROAFAroa Biosurgery0 0 0 -
Is SMGRF or AROAF More Risky?
Summerset Group Holdings Ltd. has a beta of -0.179, which suggesting that the stock is 117.891% less volatile than S&P 500. In comparison Aroa Biosurgery has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SMGRF or AROAF?
Summerset Group Holdings Ltd. has a quarterly dividend of $0.07 per share corresponding to a yield of 2.02%. Aroa Biosurgery offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Summerset Group Holdings Ltd. pays 16.94% of its earnings as a dividend. Aroa Biosurgery pays out -- of its earnings as a dividend. Summerset Group Holdings Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMGRF or AROAF?
Summerset Group Holdings Ltd. quarterly revenues are --, which are smaller than Aroa Biosurgery quarterly revenues of --. Summerset Group Holdings Ltd.'s net income of -- is lower than Aroa Biosurgery's net income of --. Notably, Summerset Group Holdings Ltd.'s price-to-earnings ratio is 7.89x while Aroa Biosurgery's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Summerset Group Holdings Ltd. is 8.25x versus -- for Aroa Biosurgery. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMGRFSummerset Group Holdings Ltd.8.25x 7.89x -- -- AROAFAroa Biosurgery-- -- -- --
-
Which has Higher Returns SMGRF or FSPKF?
Fisher & Paykel Healthcare Corp. Ltd. has a net margin of -- compared to Summerset Group Holdings Ltd.'s net margin of 29.46%. Summerset Group Holdings Ltd.'s return on equity of 12.83% beat Fisher & Paykel Healthcare Corp. Ltd.'s return on equity of 19.71%.
Company Gross Margin Earnings Per Share Invested Capital SMGRFSummerset Group Holdings Ltd.-- -- $2.6B FSPKFFisher & Paykel Healthcare Corp. Ltd.41.41% $0.36 $1.1B -
What do Analysts Say About SMGRF or FSPKF?
Summerset Group Holdings Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Fisher & Paykel Healthcare Corp. Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Summerset Group Holdings Ltd. has higher upside potential than Fisher & Paykel Healthcare Corp. Ltd., analysts believe Summerset Group Holdings Ltd. is more attractive than Fisher & Paykel Healthcare Corp. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SMGRFSummerset Group Holdings Ltd.0 0 0 FSPKFFisher & Paykel Healthcare Corp. Ltd.0 0 0 -
Is SMGRF or FSPKF More Risky?
Summerset Group Holdings Ltd. has a beta of -0.179, which suggesting that the stock is 117.891% less volatile than S&P 500. In comparison Fisher & Paykel Healthcare Corp. Ltd. has a beta of 1.237, suggesting its more volatile than the S&P 500 by 23.67%.
-
Which is a Better Dividend Stock SMGRF or FSPKF?
Summerset Group Holdings Ltd. has a quarterly dividend of $0.07 per share corresponding to a yield of 2.02%. Fisher & Paykel Healthcare Corp. Ltd. offers a yield of 1.59% to investors and pays a quarterly dividend of $0.17 per share. Summerset Group Holdings Ltd. pays 16.94% of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd. pays out 77.61% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMGRF or FSPKF?
Summerset Group Holdings Ltd. quarterly revenues are --, which are smaller than Fisher & Paykel Healthcare Corp. Ltd. quarterly revenues of $723.8M. Summerset Group Holdings Ltd.'s net income of -- is lower than Fisher & Paykel Healthcare Corp. Ltd.'s net income of $213.2M. Notably, Summerset Group Holdings Ltd.'s price-to-earnings ratio is 7.89x while Fisher & Paykel Healthcare Corp. Ltd.'s PE ratio is 51.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Summerset Group Holdings Ltd. is 8.25x versus 10.22x for Fisher & Paykel Healthcare Corp. Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMGRFSummerset Group Holdings Ltd.8.25x 7.89x -- -- FSPKFFisher & Paykel Healthcare Corp. Ltd.10.22x 51.00x $723.8M $213.2M
-
Which has Higher Returns SMGRF or PFGTF?
Pacific Edge Ltd. has a net margin of -- compared to Summerset Group Holdings Ltd.'s net margin of --. Summerset Group Holdings Ltd.'s return on equity of 12.83% beat Pacific Edge Ltd.'s return on equity of -72.02%.
Company Gross Margin Earnings Per Share Invested Capital SMGRFSummerset Group Holdings Ltd.-- -- $2.6B PFGTFPacific Edge Ltd.-- -- $15.1M -
What do Analysts Say About SMGRF or PFGTF?
Summerset Group Holdings Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Pacific Edge Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Summerset Group Holdings Ltd. has higher upside potential than Pacific Edge Ltd., analysts believe Summerset Group Holdings Ltd. is more attractive than Pacific Edge Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SMGRFSummerset Group Holdings Ltd.0 0 0 PFGTFPacific Edge Ltd.0 0 0 -
Is SMGRF or PFGTF More Risky?
Summerset Group Holdings Ltd. has a beta of -0.179, which suggesting that the stock is 117.891% less volatile than S&P 500. In comparison Pacific Edge Ltd. has a beta of -3.385, suggesting its less volatile than the S&P 500 by 438.481%.
-
Which is a Better Dividend Stock SMGRF or PFGTF?
Summerset Group Holdings Ltd. has a quarterly dividend of $0.07 per share corresponding to a yield of 2.02%. Pacific Edge Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Summerset Group Holdings Ltd. pays 16.94% of its earnings as a dividend. Pacific Edge Ltd. pays out -- of its earnings as a dividend. Summerset Group Holdings Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMGRF or PFGTF?
Summerset Group Holdings Ltd. quarterly revenues are --, which are smaller than Pacific Edge Ltd. quarterly revenues of --. Summerset Group Holdings Ltd.'s net income of -- is lower than Pacific Edge Ltd.'s net income of --. Notably, Summerset Group Holdings Ltd.'s price-to-earnings ratio is 7.89x while Pacific Edge Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Summerset Group Holdings Ltd. is 8.25x versus 19.89x for Pacific Edge Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMGRFSummerset Group Holdings Ltd.8.25x 7.89x -- -- PFGTFPacific Edge Ltd.19.89x -- -- --
-
Which has Higher Returns SMGRF or RHCGF?
Ryman Healthcare Ltd. has a net margin of -- compared to Summerset Group Holdings Ltd.'s net margin of --. Summerset Group Holdings Ltd.'s return on equity of 12.83% beat Ryman Healthcare Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SMGRFSummerset Group Holdings Ltd.-- -- $2.6B RHCGFRyman Healthcare Ltd.-- -- -- -
What do Analysts Say About SMGRF or RHCGF?
Summerset Group Holdings Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Ryman Healthcare Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Summerset Group Holdings Ltd. has higher upside potential than Ryman Healthcare Ltd., analysts believe Summerset Group Holdings Ltd. is more attractive than Ryman Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SMGRFSummerset Group Holdings Ltd.0 0 0 RHCGFRyman Healthcare Ltd.0 0 0 -
Is SMGRF or RHCGF More Risky?
Summerset Group Holdings Ltd. has a beta of -0.179, which suggesting that the stock is 117.891% less volatile than S&P 500. In comparison Ryman Healthcare Ltd. has a beta of 0.513, suggesting its less volatile than the S&P 500 by 48.743%.
-
Which is a Better Dividend Stock SMGRF or RHCGF?
Summerset Group Holdings Ltd. has a quarterly dividend of $0.07 per share corresponding to a yield of 2.02%. Ryman Healthcare Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Summerset Group Holdings Ltd. pays 16.94% of its earnings as a dividend. Ryman Healthcare Ltd. pays out -- of its earnings as a dividend. Summerset Group Holdings Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMGRF or RHCGF?
Summerset Group Holdings Ltd. quarterly revenues are --, which are smaller than Ryman Healthcare Ltd. quarterly revenues of --. Summerset Group Holdings Ltd.'s net income of -- is lower than Ryman Healthcare Ltd.'s net income of --. Notably, Summerset Group Holdings Ltd.'s price-to-earnings ratio is 7.89x while Ryman Healthcare Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Summerset Group Holdings Ltd. is 8.25x versus 2.72x for Ryman Healthcare Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMGRFSummerset Group Holdings Ltd.8.25x 7.89x -- -- RHCGFRyman Healthcare Ltd.2.72x -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
